Ashland Q4 Earnings Miss Estimates on Portfolio Actions, Revenues Down
Werte in diesem Artikel
Ashland Global Holdings Inc. ASH recorded a profit of $32 million or 71 cents per share for the fourth-quarter fiscal 2025 (ended Sept. 30, 2025) compared with a profit of $16 million or 33 cents in the prior-year quarter. Barring one-time items, adjusted earnings were $1.08 per share, down from the year-ago quarter figure of $1.26. The bottom line missed the Zacks Consensus Estimate of $1.17. Sales were down 8% year over year to $478 million. The top line beat the Zacks Consensus Estimate of $474 million. Sales for the fiscal fourth quarter were adversely impacted by the portfolio optimization actions involving curtailing or divesting certain lower-margin products, lower volumes in Specialty Additives and reduced pricing. Ashland Inc. Price, Consensus and EPS Surprise Ashland Inc. price-consensus-eps-surprise-chart | Ashland Inc. QuoteASH’s Segment HighlightsLife Sciences: Sales in the segment were down 10% year over year to $173 million in the reported quarter. The Zacks Consensus Estimate for the same was $172 million. The decline was primarily caused by the portfolio optimization. Personal Care: Sales in the division declined 7% year over year to $151 million. The metric surpassed the Zacks Consensus Estimate of $148 million. The decrease was primarily due to portfolio optimization, mainly attributed to the divestiture of the Avoca business line. Specialty Additives: Sales in the segment fell 9% year over year to $131 million but beat the Zacks Consensus Estimate of $129 million. The decline was primarily due to the portfolio actions, including the divestment of the low-margin construction business. Intermediates: Sales in the segment went down 8% year over year to $33 million. The figure also missed the consensus estimate of $34 million. Overall sales decreased, mostly due to lower prices and reduced merchant volumes. ASH’s FinancialsCash and cash equivalents were $215 million at the end of the quarter, up around 3.9% sequentially. Long-term debt was $1,384 million, up roughly 2.6% over the prior quarter. ASH’s OutlookFor fiscal 2026, Ashland expects sales to be in the range of $1.835-$1.905 billion and adjusted EBITDA to be $400-$430 million. ASH’s Price PerformanceShares of Ashland have lost 37.1% in the past year compared with a 12.7% decline in the industry. Image Source: Zacks Investment ResearchASH’s Zacks Rank & Key PicksASH currently carries a Zacks Rank #5 (Strong Sell). Some better-ranked stocks worth a look in the basic materials space are AngloGold Ashanti plc AU, Integra Resources Corp. ITRG and U.S. Gold Corp. USAU. AngloGold is scheduled to report third-quarter results on Nov. 11. AU carries a Zacks Rank #1 (Strong Buy) at present. The Zacks Consensus Estimate for AU’s third-quarter earnings is pegged at $1.34, indicating a 139.3% year-over-year growth. You can see the complete list of today’s Zacks #1 Rank stocks here.Integra Resources is scheduled to report third-quarter results on Nov. 12. ITRG carries a Zacks Rank #2 at present. The consensus estimate for ITRG’s third-quarter earnings is pegged at 13 cents, indicating a 262.5% year-over-year growth. U.S. Gold is expected to report fiscal second-quarter results on Dec. 15. USAU carries a Zacks Rank #2 at present. The Zacks Consensus Estimate for USAU’s second-quarter earnings is pegged at a loss of 13 cents, indicating a 35% year-over-year growth.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ashland Inc. (ASH): Free Stock Analysis Report AngloGold Ashanti PLC (AU): Free Stock Analysis Report US Gold Corp (USAU): Free Stock Analysis Report Integra Resources Corp. (ITRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Ashland Global und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Ashland Global
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ashland Global
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Ashland Global Holdings Inc
Analysen zu Ashland Global Holdings Inc
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.03.2018 | Ashland Global Outperform | BMO Capital Markets | |
| 31.01.2018 | Ashland Global Neutral | Monness, Crespi, Hardt & Co. | |
| 16.05.2017 | Ashland Global Buy | Monness, Crespi, Hardt & Co. | |
| 28.11.2016 | Ashland Buy | Deutsche Bank AG | |
| 27.01.2016 | Ashland Buy | Monness, Crespi, Hardt & Co. |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.03.2018 | Ashland Global Outperform | BMO Capital Markets | |
| 16.05.2017 | Ashland Global Buy | Monness, Crespi, Hardt & Co. | |
| 28.11.2016 | Ashland Buy | Deutsche Bank AG | |
| 27.01.2016 | Ashland Buy | Monness, Crespi, Hardt & Co. | |
| 23.09.2015 | Ashland Buy | Deutsche Bank AG |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.01.2018 | Ashland Global Neutral | Monness, Crespi, Hardt & Co. | |
| 04.01.2007 | Update Ashland Inc.: Hold | Matrix Research | |
| 03.01.2007 | Update Ashland Inc.: Hold | KeyBanc Capital Markets / McDonald | |
| 05.12.2006 | Update Ashland Inc.: Neutral | JP Morgan | |
| 15.11.2006 | Update Ashland Inc.: Neutral | Credit Suisse |
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ashland Global Holdings Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen